American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis

Endocr Pract. Jul-Aug 2001;7(4):293-312.

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alendronate / adverse effects
  • Alendronate / therapeutic use
  • Bone Density
  • Bone and Bones / injuries
  • Calcitonin / adverse effects
  • Calcitonin / therapeutic use
  • Calcium, Dietary / administration & dosage
  • Dietary Supplements
  • Estrogen Replacement Therapy / adverse effects
  • Female
  • Fractures, Bone
  • Humans
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / prevention & control*
  • Osteoporosis, Postmenopausal / therapy*
  • Raloxifene Hydrochloride / adverse effects
  • Raloxifene Hydrochloride / therapeutic use
  • Risk Factors

Substances

  • Calcium, Dietary
  • Raloxifene Hydrochloride
  • Calcitonin
  • Alendronate